Hasil Pencarian  ::  Simpan CSV :: Kembali

"Annotation. Gain a full understanding of the basic science andclinical use of drugs with the most up-to-date andcomprehensive pharmacology text in the health sciences400 ILLUSTRATIONS--MANY IN FULL COLOROrganized to reflect the course sequence in many pharmacology courses and in integrated curricula, Basic &​ Clinical Pharmacology covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors' many years of experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students.Coverage that spans every aspect of medical pharmacology:Encompasses every aspect of medical pharmacology including botanicals and over-the-counter drugsNew chapter on pharmacogenomics with important examplesEmphasis is placed on discussion of druggroups and prototypesClinically relevant, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effectsFull-color presentation with more than 400 illustrationsCase studies introduce clinical problems in most chaptersSummary tables and diagrams encapsulate important informationIncludes many new drugsA Generic Name/​Trade Name Table appears at the end of most chapters for easy reference when writing a chart order or prescription."

"Penelitian ini bertujuan untuk menentukan clinical pathway dan biaya perawatan odontectomy M3 impaksi tanpa penyakit penyerta di RS Islam Jakarta Cempaka Putih pada tahun 2009, dengan melakukan riset operasional secara kualitatif dan kuantitatif dengan rancangan retrospective. Terdapat 72 sampel yang memenuhi kriteria inklusi dan eksklusi. Data yang diolah adalah data morbiditas tahun 2008- 2009 dan data keuangan tahun 2009. Biaya odontectomy M3 impaksi tanpa penyakit penyerta dihitung dengan metode ABC (Activity Based Costing) dengan struktur biaya investasi, operasional, pemeliharaan dan biaya tidak langsung. Berdasarkan clinical pathway, biaya odontectomy M3 impaksi tanpa penyakit penyerta adalah Rp. 1.057.163,- (mesio angular), Rp. 1.241.810,- (horizontal), Rp. 1.445.210,- (terpendam) untuk odontectomy anesthesi lokal rawat jalan dan Rp. 6.540.846,- untuk odontectomy anesthesi umum one day care. Sedangkan CRR (Cost Revenue Rate) masing-masing adalah 72 % (mesio angular), 72 % (horizontal), 77 % (terpendam) dan 65 % (odontectomy anestesi umum-one day care).

---

This research is aimed to obtain clinical pathway and cost of treatment third-molar impaction odontectomy at RS Islam Jakarta Cempaka Putih in 2009, by doing operational research qualitatively and quantitatively, using retrospective methode. There are 72 samples which comply with included and excluded criteria. Data that used in this research are morbidity data in 2008-2009 and financial data in 2009.

The cost is accounted by ABC (Activity Based Costing) method, which the cost structures are investation, operational, maintainance and indirect cost. Based on clinical pathway at RS Islam Jakarta Cempaka Putih, costs of treatment third molar impaction odontectomy are Rp. 1.057.163,- (mesio angular), Rp. 1.241.810,- (horizontal), Rp. 1.445.210,- (embedeed) for local anesthesiaambulatory treatment and Rp. 6.540.846,- for general anesthesia- one day care treatment. In addition, CRR (Cost Revenue Rate) of each treatment are 72 % (mesio angular), 72 % (horizontal), 77 % (embedded) dan 65 % (odontectomy anestesi umum-one day care)."

"Peptic ulcer atau ulkus peptikum adalah defek pada dinding mukosa lambung atau duodenum yang meluas melalui mukosa muskularis ke lapisan submukosa yang lebih dalam. Dalam penanganan ulkus peptikum di rumah sakit, perlu dimiliki clinical pathway terkait ulkus peptikum dimulai dari diagnosis hingga pemilihan terapi untuk pasien. Pembuatan clinical pathway dan algoritma terapi pengobatan ulkus peptikum di Rumah Sakit Universitas Indonesia (RSUI) harus menyesuaikan dengan obat-obatan yang digunakan di RSUI. Obat antisekresi yang digunakan untuk penyakit ulkus peptikum termasuk antagonis reseptor H2 dan proton pump inhibitor (PPI). Algoritma terapi diawali dengan diagnosis saat pasien datang. Khusus untuk pasien lanjut usia perlu dilakukan endoskopi untuk mengetahui status ulkus. Setelah diagnosis ditegakkan maka pengobatan ulkus peptikum dilakukan mengikuti dengan regimen terapi ulkus. Tidak ada perbedaan pada pemilihan terapi ulkus peptikum untuk pasien anak, dewasa, dan lanjut usia. Ulkus peptikum memiliki beragam pilihan terapi yang dapat digunakan sesuai dengan kondisi pasien. Obat golongan Antagonis reseptor H2 lebih sesuai diberikan kepada pasien yang sedang menjalani terapi menggunakan clopidogrel karena memiliki risiko pendarahan yang lebih kecil sementara obat golongan Proton Pump Inhibitor lebih sesuai diberikan kepada pasien dengan pH lambung yang rendah karena memiliki kemampuan supresi asam yang lebih baik.

---

Peptic ulcer or peptic ulcer is a defect in the mucosal wall of the stomach or duodenum that extends through the muscularis mucosa into the deeper submucosal layers. In treating peptic ulcer in a hospital, it is necessary to have a clinical pathway related to peptic ulcer starting from diagnosis to selecting therapy for the patient. The creation of clinical pathways and therapeutic algorithms for treating peptic ulcers at the University of Indonesia Hospital (RSUI) must adapt to the drugs used at RSUI. Antisecretory drugs used for peptic ulcer disease include H2 receptor antagonists and proton pump inhibitors (PPIs). The therapy algorithm begins with a diagnosis when the patient arrives. Especially for elderly patients, endoscopy is necessary to determine the status of the ulcer. After the diagnosis is established, the treatment of peptic ulcer is carried out following the ulcer therapy regimen. There was no difference in the choice of peptic ulcer therapy for pediatric, adult, and elderly patients. Peptic ulcers have a variety of therapeutic options that can be used according to the patient's condition. H2 receptor antagonist drugs are more suitable for patients who are undergoing therapy using clopidogrel because they have a smaller risk of bleeding while Proton Pump Inhibitor class drugs are more suitable for patients with low gastric pH because they have better acid suppression capabilities.

"